About Daiichi Sankyo UK

Daiichi Sankyo UK creates and supplies innovative pharmaceutical products to help the NHS deliver patient care in cardiovascular disease and oncology. With over 100 years of scientific expertise and corporate origins in Japan, the company was founded in Europe in 2006 through the merger of two established pharmaceutical companies. The company is part of a global network spanning more than 20 countries, with European headquarters in Munich and approximately 2,500 employees across 14 European countries and Canada. Daiichi Sankyo pioneers leading pharmaceuticals that have contributed to the improvement of countless lives worldwide.